State of Wyoming’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-11,015
| Closed | -$45.3K | – | 1884 |
|
2024
Q1 | $45.3K | Sell |
11,015
-22,967
| -68% | -$94.4K | 0.01% | 1333 |
|
2023
Q4 | $143K | Buy |
33,982
+15,189
| +81% | +$64.1K | 0.03% | 770 |
|
2023
Q3 | $81.2K | Buy |
18,793
+5,520
| +42% | +$23.8K | 0.02% | 1007 |
|
2023
Q2 | $87.5K | Buy |
13,273
+8,522
| +179% | +$56.2K | 0.03% | 905 |
|
2023
Q1 | $32.3K | Sell |
4,751
-25,370
| -84% | -$172K | 0.01% | 1244 |
|
2022
Q4 | $223K | Buy |
30,121
+9,688
| +47% | +$71.6K | 0.07% | 257 |
|
2022
Q3 | $202K | Buy |
20,433
+15,019
| +277% | +$148K | 0.1% | 195 |
|
2022
Q2 | $59K | Sell |
5,414
-7,217
| -57% | -$78.6K | 0.04% | 839 |
|
2022
Q1 | $142K | Sell |
12,631
-6,318
| -33% | -$71K | 0.07% | 368 |
|
2021
Q4 | $297K | Buy |
18,949
+9,379
| +98% | +$147K | 0.14% | 110 |
|
2021
Q3 | $164K | Sell |
9,570
-612
| -6% | -$10.5K | 0.11% | 228 |
|
2021
Q2 | $219K | Buy |
+10,182
| New | +$219K | 0.14% | 168 |
|